These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19120266)

  • 21. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
    Vanikar AV; Trivedi HL; Thakkar UG
    Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
    Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
    Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human allograft rejection in humanized mice: a historical perspective.
    Brehm MA; Shultz LD
    Cell Mol Immunol; 2012 May; 9(3):225-31. PubMed ID: 22327213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of stem cell-derived β-cells from patients with type 1 diabetes.
    Millman JR; Xie C; Van Dervort A; Gürtler M; Pagliuca FW; Melton DA
    Nat Commun; 2016 May; 7():11463. PubMed ID: 27163171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune islet damage mediated by insulin-specific T cells.
    Crawford M; Daniel D; Wegmann D; Yang H; Gill RG
    Transplant Proc; 1997; 29(1-2):758-9. PubMed ID: 9123512
    [No Abstract]   [Full Text] [Related]  

  • 27. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes.
    Levetan CS; Pierce SM
    Endocr Pract; 2013; 19(2):301-12. PubMed ID: 23186955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice.
    Kang HM; Kim J; Park S; Kim J; Kim H; Kim KS; Lee EJ; Seo SI; Kang SG; Lee JE; Lim H
    Stem Cells; 2009 Aug; 27(8):1999-2008. PubMed ID: 19544420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta cells within single human islets originate from multiple progenitors.
    Scharfmann R; Xiao X; Heimberg H; Mallet J; Ravassard P
    PLoS One; 2008; 3(10):e3559. PubMed ID: 18958289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cell mass and type 1 diabetes: going, going, gone?
    Akirav E; Kushner JA; Herold KC
    Diabetes; 2008 Nov; 57(11):2883-8. PubMed ID: 18971435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
    Gerling IC; Serreze DV; Christianson SW; Leiter EH
    Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.
    Razavi R; Chan Y; Afifiyan FN; Liu XJ; Wan X; Yantha J; Tsui H; Tang L; Tsai S; Santamaria P; Driver JP; Serreze D; Salter MW; Dosch HM
    Cell; 2006 Dec; 127(6):1123-35. PubMed ID: 17174891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk Between Immunity System Cells and Pancreas. Transformation of Stem Cells Used in the 3D Bioprinting Process as a Personalized Treatment Method for Type 1 Diabetes.
    Niedźwiedzka-Rystwej P; Wołącewicz M; Cywoniuk P; Klak M; Wszoła M
    Arch Immunol Ther Exp (Warsz); 2020 Apr; 68(2):13. PubMed ID: 32297019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of autoimmune diabetes and islet allograft rejection by beta cell expression of XIAP: Insight into possible mechanisms of local immunomodulation.
    Obach M; Hosseini-Tabatabaei A; Montane J; Wind K; Soukhatcheva G; Dai D; Priatel JJ; Orban PC; Verchere CB
    Mol Cell Endocrinol; 2018 Dec; 477():48-56. PubMed ID: 29883690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-cell replacement for insulin-dependent diabetes mellitus.
    Efrat S
    Adv Drug Deliv Rev; 2008 Jan; 60(2):114-23. PubMed ID: 18022276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
    Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation for the treatment of autoimmunity in type 1 diabetes.
    LoCascio SA; Spinelli J; Kurtz J
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):29-37. PubMed ID: 20955158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell therapy for diabetes: stem cells, progenitors or beta-cell replication?
    Gonez LJ; Knight KR
    Mol Cell Endocrinol; 2010 Jul; 323(1):55-61. PubMed ID: 20026173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.